(Total Views: 618)
Posted On: 05/14/2019 7:36:24 PM
Post# of 30066
.jpg)
New comments from Dr. Weiss:
https://talkmarkets.com/content/stocks--equit...ost=218803
Hi Chuck, Just logged in for the first time since this went live, and seeing some great feedback. We are putting together our data package, but need to take care of a few things before we can publicise it. The KOLs we have canvased and the Pharma companies have all told us that any diagnostic that pushes the diagnosis earlier will be highly sought after
Chuck, i want to add, the quote of 'could be as high is 90%' was clearly aspirational based on targets that have been developed with pharma in mind, to your second question.
Harry, Our KOLs and Pharma contacts are all eager as well
Sorry for the delay Chuck, no trying to be evasive, I was traveling for the last 2 weeks, There was a conference in Vegas and followed by investor meetings in NYC. To directly answer your question we are working on getting the data out publicly in the right time and forum. There is a process here we are trying to be cognisant of and stay within the lines.
https://talkmarkets.com/content/stocks--equit...ost=218803
Hi Chuck, Just logged in for the first time since this went live, and seeing some great feedback. We are putting together our data package, but need to take care of a few things before we can publicise it. The KOLs we have canvased and the Pharma companies have all told us that any diagnostic that pushes the diagnosis earlier will be highly sought after
Chuck, i want to add, the quote of 'could be as high is 90%' was clearly aspirational based on targets that have been developed with pharma in mind, to your second question.
Harry, Our KOLs and Pharma contacts are all eager as well
Sorry for the delay Chuck, no trying to be evasive, I was traveling for the last 2 weeks, There was a conference in Vegas and followed by investor meetings in NYC. To directly answer your question we are working on getting the data out publicly in the right time and forum. There is a process here we are trying to be cognisant of and stay within the lines.
(2)
(0)
